US physician group calls for ban on direct to consumer drug advertisingBMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h6230 (Published 18 November 2015) Cite this as: BMJ 2015;351:h6230
- Michael McCarthy
The American Medical Association has called for a ban on all direct to consumer advertising of prescription drugs and medical devices. The new policy, adopted on 17 November at the AMA’s interim meeting in Atlanta, Georgia, also called for the federal government to limit anticompetitive behavior by drug companies.
In a statement Patrice A Harris, AMA board chair elect, said that direct to consumer advertising was inflating demand for new and more expensive drugs that may not be appropriate.“Today’s vote in support …